Skip to main content
logo
Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
63.40
+4.75 (8.10%)
At close: Aug 25, 2026, 4:00 PM EDT
64.51
+1.11 (1.75%)
After-hours: Aug 25, 2026, 7:52 PM EDT

Spruce Biosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
--4.9110.09--
Revenue Growth
---51.32%---
Cost of Revenue
22.9513.6246.4249.4335.2-
Gross Profit
-22.95-13.62-41.51-39.34-35.2-
Selling, General & Admin
16.9814.9914.6412.6512.0911.37
Research & Development
-----30.7
Operating Expenses
16.9814.9914.6412.6512.0942.07
Operating Income
-39.93-28.61-56.15-51.99-47.28-42.07
Interest Expense
-1.8-0.09-0.31-0.48-0.42-0.35
Interest & Investment Income
1.871.143.424.561.520.12
Other Non Operating Income (Expenses)
-3.6-3.5----
EBT Excluding Unusual Items
-43.45-31.07-53.04-47.92-46.18-42.29
Merger & Restructuring Charges
-0.9-0.9----
Legal Settlements
-1.9-1.9----
Other Unusual Items
-5.1-5.1----
Pretax Income
-51.35-38.97-53.04-47.92-46.18-42.29
Net Income
-51.35-38.97-53.04-47.92-46.18-42.29
Net Income to Common
-51.35-38.97-53.04-47.92-46.18-42.29
Net Income Growth
------
Shares Outstanding (Basic)
111100
Shares Outstanding (Diluted)
111100
Shares Change
149.78%39.34%7.14%63.68%0.71%289.93%
EPS (Basic)
-36.05-50.83-96.40-93.32-147.21-135.78
EPS (Diluted)
-36.05-50.83-96.40-93.32-147.21-135.78
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-42.77-33.33-55.96-33.28-41.69-35.97
Free Cash Flow Per Share
-30.02-43.47-101.73-64.82-132.90-115.48
Operating Margin
---1143.37%-515.34%--
Profit Margin
---1079.94%-474.96%--
Free Cash Flow Margin
---1139.56%-329.88%--
EBITDA
-39.04-28.59-56.11-51.92-47.21-42
D&A For EBITDA
0.890.020.050.070.070.07
EBIT
-39.93-28.61-56.15-51.99-47.28-42.07